Navigation Links
Cyberonics Reports Strong Fiscal 2010 First Quarter Results
Date:8/19/2009

t-resistant depression indication; adverse changes in coverage or reimbursement amounts by third-parties; intellectual property protection and potential infringement claims; maintaining compliance with government regulations and obtaining necessary government approvals for new indications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates of future expenses and sales; the results of the previously disclosed governmental inquiries; the potential identification of material weaknesses in our internal controls over financial reporting; risks and costs associated with such governmental inquiries and any litigation relating thereto or to our stock option grants, procedures, and practices and other risks detailed from time to time in our filings with the Securities and Exchange Commission (SEC). For a detailed discussion of these and other cautionary statements, please refer to our most recent filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended April 24, 2009.

    Contact information

    Greg Browne, CFO
    Cyberonics, Inc.
    100 Cyberonics Blvd.
    Houston, TX 77058
    Main: (281) 228-7262
    Fax: (281) 218-9332
    ir@cyberonics.com


                            CYBERONICS, INC. AND SUBSIDIARY
                         CONSOLIDATED STATEMENTS OF OPERATIONS
                                       (Unaudited)

                                                        For the
                                                  Thirteen Weeks Ended
                                                  --------------------
                                               July 24,           July 25,
                                                 2009               2008
                                 
'/>"/>
SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related medicine news :

1. Cyberonics to Present at Canaccord Adams 29th Annual Global Growth Conference
2. Cyberonics Announces Conference Call to Discuss Fiscal Year 2010 First Quarter Financial Results
3. Cyberonics Announces Exclusive Distribution Agreement With Nihon Kohden in Japan
4. Cyberonics Names Bryan D. Olin, Ph.D. Vice President, Quality
5. Cyberonics Announces Conference Call to Discuss Fourth Quarter and Fiscal Year 2009 Financial Results
6. Cyberonics Continues Strong Sales Growth and Profitability in Fiscal 2009 Third Quarter
7. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Third Quarter Financial Results
8. Cyberonics Names Milton M. Morris, Ph.D. Vice President, Research & Development
9. Cyberonics to Present at Piper Jaffray 20th Annual Health Care Conference
10. Cyberonics Reports Strong Sales Growth and Profitability in Fiscal 2009 Second Quarter
11. Cyberonics Announces Conference Call to Discuss Fiscal Year 2009 Second Quarter Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2014)... San Jose, CA (PRWEB) August 22, 2014 ... are now offering a new teeth whitening technique. Air ... during regular cleaning appointments. , Dark teeth can be ... into two categories: external stains and internal stains. External ... Internal stains can be caused by certain medications, such ...
(Date:8/22/2014)... found that targeted automated alerts in electronic health ... patients with urinary catheters. In addition, when the ... of improvement dramatically increased. , The alerts help ... in the first place and then alert them ... not been removed within a recommended time period. ...
(Date:8/22/2014)... August 22, 2014 Natural Clear Vision ... to restore his own vision from legally blind to perfect ... an investigative review. , “There is a huge portion ... for everyday function, and most people just think that’s the ... eye surgery that can be pretty risky at times,” reports ...
(Date:8/22/2014)... found in the circulating free tumor DNA (ctDNA) from ... patients correlates well with the EGFR mutations from patient-matched ... therapy is approved for EGFR activating mutation positive patients ... status is with DNA derived directly from tumor tissue, ... abundant and less invasive source of tumor DNA may ...
(Date:8/22/2014)... (PRWEB) August 22, 2014 Testosterone ... filed in U.S. courts on behalf of men ... their use of prescription low testosterone therapies, Bernstein ... new claim was filed against Pfizer Inc. on ... suffered life-threatening heart issues due to his use ...
Breaking Medicine News(10 mins):Health News:Japantown Dental Introduces Air Polishing 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 2Health News:Penn study: Electronic alerts significantly reduce catheter-associated urinary tract infections 3Health News:Natural Clear Vision: Review Exposes Kevin Richardson’s Program for Restoring Vision Naturally 2Health News:High concordance between EGFR mutations from circulating-free tumor DNA and tumor tissue in non-small cell lung cancer 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4
... than those that are not. A new study says ... as celiac disease”// ,CD, also known as celiac ... to result from the activation of both a cell-mediated ... glutens (prolamins and glutenins) found in wheat, barley, rye, ...
... Chemistry and Industry magazine says that tropical plants imported ... dengue and other related illnesses. // ,The Asian ... and this species was detected in the Netherlands leading ... These mosquitoes were detected in imported bamboo in a ...
... dengue fever vaccine full of promise is being tried in ... the GlaxoSmithKline vaccine //have been completed in the US and ... finished by the end of next year, Dr. Hans L. ... interest in making the vaccine available fast, given that this ...
... with anti-TNF agents (etanercept) and chemotherapy drug methotrexate ... treatment of Rheumatoid Arthritis.// Furthermore, the progression of ... over three quarters of patients. The chronic nature ... for prevention of long-term joint damage in addition ...
... Aurobindo Pharma Ltd has announced that U.S. Food ... capsules USP 250 mg & 500 mg.// ... of bacterial infections such as bronchitis, tonsillitis, ear ... has achieved another major milestone by obtaining the ...
... conducted on nearly 50 nursery school children has revealed ... it on to their children as well, //resulting in ... were considerably higher amongst the group of children studied. ... children were greater than twice the normal levels in ...
Cached Medicine News:Health News:Breastfeeding: A Boon For Cealiac Disease 2Health News:Combination Therapy With ENBREL And Methotrexate Found Effective In RA Treatment 2Health News:Children’s Stress Levels Directly Related To Maternal Job Satisfaction 2
(Date:8/22/2014)... Mich. , Aug. 22, 2014  Diplomat, ... selected as one of two winners in the ... Specialty Pharmacy Solutions, LLC. The results of the ... of Specialty Pharmacy News. Diplomat ... Diplomat University Education & Training program. Through Diplomat ...
(Date:8/22/2014)... /CNW/ - On Aug. 20, at its annual meeting ... Association (CMA) voted on and approved a delegate resolution ... cannabis. Bedrocan Cannabis Corp., a leading Canadian licensed producer ... The CMA is quite right to point ... any plant material, including medicinal cannabis. While some patients, ...
(Date:8/22/2014)... , Aug. 22, 2014  Dr. Mark Rasak ... the Diamond Lifetime Achievement Award in the field of ... of Cardiovascular Clinical Associates. Dr. Rasak has ... all major aspects of the business; overseeing the daily ... primary coronary intervention. In addition, he is an honored ...
Breaking Medicine Technology:Diplomat honored as a Top Innovator by Specialty Pharmacy News 2Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2
... Slit Lamp features easy-to-use controls to help ... to a halogen bulb that gives up ... with powers of 10X and 16X, the ... accepts commercially available C-mount cameras, allowing physicians ...
... uses state-of-the-art waveform analysis and ... a 65MHz rate to obtain ... and averages nine measurements and ... fits comfortably into the hand ...
Perfect for loading small volume samples onto agarose and polyacrylamide gels....
1000 L, Bulk Recommended for 500 and 1000 L pipettes...
Medicine Products: